{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:35:29Z","timestamp":1780623329540,"version":"3.54.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Brightside Health","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Major Depressive Disorder and Generalized Anxiety Disorder are pervasive and debilitating conditions, though treatment is often inaccessible and based on trial-and-error prescribing methods. The present observational study seeks to describe the use of a proprietary precision prescribing algorithm piloted during routine clinical practice as part of Brightside\u2019s telepsychiatry services. The primary aim is to determine the feasibility and acceptability of implementing this intervention. Secondary aims include exploring remission and symptom improvement rates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Participants were adult patients enrolled in Brightside who completed at least 12\u2009weeks of treatment for depression and\/or anxiety and received a prescription for at least one psychiatric medication. A prescription recommendation was made by Brightside\u2019s algorithm at treatment onset and was utilized for clinical decision support. Participants received baseline screening surveys of the PHQ-9 and GAD-7, and at weeks 2,4,6,8,10 and 12. Intent-to-treat (ITT) sensitivity analyses were conducted. Feasibility of the implementation was measured by the platform\u2019s ability to enroll and engage participants in timely psychiatric care, as well as offer high touch-point treatment options. Acceptability was measured by patient responses to a 5-star satisfaction rating.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Brightside accessed and treated 6248 patients from October 2018 to April 2021, treating a majority of patients within 4-days of enrollment. The average plan cost was $115\/month. 89% of participants utilized Brightside\u2019s core medication plan at a cost of $95\/month. 13.4% of patients in the study rated Brightside\u2019s services as highly satisfactory, averaging a 4.6-star rating. Furthermore, 90% of 6248 patients experienced a MCID in PHQ-9 or GAD-7 score. Remission rates were 75% (final PHQ-9 or GAD-7 score\u2009&lt;\u200910) for the study sample and 59% for the ITT sample. 69.3% of Brightside patients were treated with the medication initially prescribed at intake.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Results suggest that the present intervention may be feasible and acceptable within the assessed population. Exploratory analyses suggest that Brightside\u2019s course of treatment, guided by precision recommendations, improved patients\u2019 symptoms of anxiety and depression.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-022-04113-9","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T12:06:56Z","timestamp":1658232416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Feasibility and acceptability of a novel telepsychiatry-delivered precision prescribing intervention for anxiety and depression"],"prefix":"10.1186","volume":"22","author":[{"given":"Erin","family":"O\u2019Callaghan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6210-7992","authenticated-orcid":false,"given":"Carina","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather G.","family":"Belanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir\u00e8ne","family":"Winsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"4113_CR1","volume-title":"Facts and Statistics","author":"Anxiety and Depression Association of America","year":"2021","unstructured":"Anxiety and Depression Association of America. Facts and Statistics. 2021 [cited 2021 September 2]; Available from: https:\/\/adaa.org\/understanding-anxiety\/facts-statistics."},{"key":"4113_CR2","volume-title":"Major Depression","author":"National Institute of Mental Health","year":"2021","unstructured":"National Institute of Mental Health. Major Depression. 2021 [cited 2021 December 16]; Available from: https:\/\/www.nimh.nih.gov\/health\/statistics\/major-depression."},{"issue":"5","key":"4113_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cpr.2004.06.001","volume":"24","author":"KA Collins","year":"2004","unstructured":"Collins KA, et al. Gaps in accessing treatment for anxiety and depression: challenges for the delivery of care. Clin Psychol Rev. 2004;24(5):583\u2013616.","journal-title":"Clin Psychol Rev"},{"issue":"8","key":"4113_CR4","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1017\/S0033291710002291","volume":"41","author":"R Mojtabai","year":"2011","unstructured":"Mojtabai R, et al. Barriers to mental health treatment: results from the National Comorbidity Survey Replication. Psychol Med. 2011;41(8):1751\u201361.","journal-title":"Psychol Med"},{"issue":"6","key":"4113_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1176\/appi.ps.201400248","volume":"66","author":"ER Walker","year":"2015","unstructured":"Walker ER, et al. Insurance status, use of mental health services, and unmet need for mental health care in the United States. Psychiatr Serv. 2015;66(6):578\u201384.","journal-title":"Psychiatr Serv"},{"issue":"4","key":"4113_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1748-0361.2001.tb00288.x","volume":"17","author":"CN Bull","year":"2001","unstructured":"Bull CN, et al. Access and issues of equity in remote\/rural areas. J Rural Health. 2001;17(4):356\u20139.","journal-title":"J Rural Health"},{"issue":"10","key":"4113_CR7","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1001\/archpsyc.1981.01780350089010","volume":"38","author":"LM Koran","year":"1981","unstructured":"Koran LM. Psychiatrists' distribution across the 50 states, 1978. Arch Gen Psychiatry. 1981;38(10):1155\u20139.","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"4113_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1176\/appi.ajp.2015.14050652","volume":"172","author":"T Guo","year":"2015","unstructured":"Guo T, et al. Measurement-based care versus standard Care for Major Depression: a randomized controlled trial with blind raters. Am J Psychiatry. 2015;172(10):1004\u201313.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"4113_CR9","first-page":"11","volume":"24","author":"K Colorafi","year":"2017","unstructured":"Colorafi K, Vanselow J, Nelson T. Treating anxiety and depression in primary care: reducing barriers to access. Fam Pract Manag. 2017;24(4):11\u20136.","journal-title":"Fam Pract Manag"},{"issue":"3","key":"4113_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1468-2850.2007.00089.x","volume":"14","author":"JP Jameson","year":"2007","unstructured":"Jameson JP, Blank MB. The role of clinical psychology in rural mental health services: defining problems and developing solutions. Clin Psychol Sci Pract. 2007;14(3):283\u201398.","journal-title":"Clin Psychol Sci Pract"},{"key":"4113_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.eurpsy.2016.03.007","volume":"36","author":"A Drago","year":"2016","unstructured":"Drago A, Winding TN, Antypa N. Videoconferencing in psychiatry, a meta-analysis of assessment and treatment. Eur Psychiatry. 2016;36:29\u201337.","journal-title":"Eur Psychiatry"},{"issue":"4","key":"4113_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s10862-013-9363-4","volume":"35","author":"DF Gros","year":"2013","unstructured":"Gros DF, et al. Delivery of evidence-based psychotherapy via video telehealth. J Psychopathol Behav Assess. 2013;35(4):506\u201321.","journal-title":"J Psychopathol Behav Assess"},{"issue":"9","key":"4113_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11920-019-1074-4","volume":"21","author":"K Hariman","year":"2019","unstructured":"Hariman K, Ventriglio A, Bhugra D. The future of digital psychiatry. Curr Psychiatry Rep. 2019;21(9):88.","journal-title":"Curr Psychiatry Rep"},{"issue":"21","key":"4113_CR14","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1001\/jama.2012.5588","volume":"307","author":"DC Mohr","year":"2012","unstructured":"Mohr DC, et al. Effect of telephone-administered vs face-to-face cognitive behavioral therapy on adherence to therapy and depression outcomes among primary care patients: a randomized trial. JAMA. 2012;307(21):2278\u201385.","journal-title":"JAMA"},{"issue":"4","key":"4113_CR15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1080\/16506070903318960","volume":"38","author":"G Andersson","year":"2009","unstructured":"Andersson G, Cuijpers P. Internet-based and other computerized psychological treatments for adult depression: a meta-analysis. Cogn Behav Ther. 2009;38(4):196\u2013205.","journal-title":"Cogn Behav Ther"},{"issue":"8","key":"4113_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/JGP.0b013e31822ccd3e","volume":"20","author":"GA Brenes","year":"2012","unstructured":"Brenes GA, et al. A randomized controlled trial of telephone-delivered cognitive-behavioral therapy for late-life anxiety disorders. Am J Geriatr Psychiatry. 2012;20(8):707\u201316.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"Suppl 1","key":"4113_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1751-7893.2010.00242.x","volume":"5","author":"H Christensen","year":"2011","unstructured":"Christensen H, Reynolds J, Griffiths KM. The use of e-health applications for anxiety and depression in young people: challenges and solutions. Early Interv Psychiatry. 2011;5(Suppl 1):58\u201362.","journal-title":"Early Interv Psychiatry"},{"issue":"1","key":"4113_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/jclp.20536","volume":"65","author":"MA Reger","year":"2009","unstructured":"Reger MA, Gahm GA. A meta-analysis of the effects of internet- and computer-based cognitive-behavioral treatments for anxiety. J Clin Psychol. 2009;65(1):53\u201375.","journal-title":"J Clin Psychol"},{"issue":"3","key":"4113_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.chb.2004.10.009","volume":"22","author":"P Carlbring","year":"2006","unstructured":"Carlbring P, Andersson G. Internet and psychological treatment. How well can they be combined? Comput Hum Behav. 2006;22(3):545\u201353.","journal-title":"Comput Hum Behav"},{"issue":"1","key":"4113_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cpr.2010.09.008","volume":"31","author":"MG Newman","year":"2011","unstructured":"Newman MG, et al. A review of technology-assisted self-help and minimal contact therapies for anxiety and depression: is human contact necessary for therapeutic efficacy? Clin Psychol Rev. 2011;31(1):89\u2013103.","journal-title":"Clin Psychol Rev"},{"issue":"3","key":"4113_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.neubiorev.2004.03.008","volume":"28","author":"JG Proudfoot","year":"2004","unstructured":"Proudfoot JG. Computer-based treatment for anxiety and depression: is it feasible? Is it effective? Neurosci Biobehav Rev. 2004;28(3):353\u201363.","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"4113_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1089\/tmj.2011.0126","volume":"18","author":"J Chong","year":"2012","unstructured":"Chong J, Moreno F. Feasibility and acceptability of clinic-based telepsychiatry for low-income Hispanic primary care patients. Telemed J E Health. 2012;18(4):297\u2013304.","journal-title":"Telemed J E Health"},{"issue":"3","key":"4113_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1089\/tmj.2011.0107","volume":"18","author":"J Chung-Do","year":"2012","unstructured":"Chung-Do J, et al. Rural mental health: implications for telepsychiatry in clinical service, workforce development, and organizational capacity. Telemed J E Health. 2012;18(3):244\u20136.","journal-title":"Telemed J E Health"},{"key":"4113_CR24","first-page":"1f","volume":"10","author":"S Deslich","year":"2013","unstructured":"Deslich S, et al. Telepsychiatry in the 21(st) century: transforming healthcare with technology. Perspect Health Inf Manag. 2013;10:1f.","journal-title":"Perspect Health Inf Manag"},{"key":"4113_CR25","unstructured":"Psychiatry Online. Telepsychiatry and Health Technologies. [cited 2021 September 16]; Available from: https:\/\/html5-player.libsyn.com\/embed\/episode\/id\/9829475\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/003399\/."},{"key":"4113_CR26","doi-asserted-by":"publisher","first-page":"100317","DOI":"10.1016\/j.invent.2020.100317","volume":"20","author":"TR Wind","year":"2020","unstructured":"Wind TR, et al. The COVID-19 pandemic: the \u2018black swan\u2019 for mental health care and a turning point for e-health. Internet Interv. 2020;20:100317.","journal-title":"Internet Interv"},{"issue":"3","key":"4113_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/wps.20472","volume":"16","author":"J Firth","year":"2017","unstructured":"Firth J, et al. The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials. World Psychiatry. 2017;16(3):287\u201398.","journal-title":"World Psychiatry"},{"issue":"5","key":"4113_CR28","doi-asserted-by":"publisher","first-page":"e17458","DOI":"10.2196\/17458","volume":"8","author":"T Lecomte","year":"2020","unstructured":"Lecomte T, et al. Mobile apps for mental health issues: Meta-review of Meta-analyses. JMIR Mhealth Uhealth. 2020;8(5):e17458.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"8","key":"4113_CR29","doi-asserted-by":"publisher","first-page":"e15506","DOI":"10.2196\/15506","volume":"22","author":"LM Betthauser","year":"2020","unstructured":"Betthauser LM, et al. Mobile app for mental health monitoring and clinical outreach in veterans: mixed methods feasibility and acceptability study. J Med Internet Res. 2020;22(8):e15506.","journal-title":"J Med Internet Res"},{"issue":"9","key":"4113_CR30","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1017\/S1461145710000866","volume":"13","author":"EH Wong","year":"2010","unstructured":"Wong EH, et al. Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective. Int J Neuropsychopharmacol. 2010;13(9):1269\u201384.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9","key":"4113_CR31","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nrn2218","volume":"8","author":"SE Hyman","year":"2007","unstructured":"Hyman SE. Can neuroscience be integrated into the DSM-V? Nat Rev Neurosci. 2007;8(9):725\u201332.","journal-title":"Nat Rev Neurosci"},{"issue":"6234","key":"4113_CR32","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1126\/science.aab2358","volume":"348","author":"TR Insel","year":"2015","unstructured":"Insel TR, Cuthbert BN, Medicine. Brain disorders? Precisely. Science. 2015;348(6234):499\u2013500.","journal-title":"Science"},{"issue":"23","key":"4113_CR33","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1056\/NEJMsb1503104","volume":"372","author":"JL Jameson","year":"2015","unstructured":"Jameson JL, Longo DL. Precision medicine--personalized, problematic, and promising. N Engl J Med. 2015;372(23):2229\u201334.","journal-title":"N Engl J Med"},{"key":"4113_CR34","volume-title":"How Advances in Precision Oncology Are Shaping a New Diagnostic and Treatment Frontier. Perspectives in Precision Oncology","author":"AJMC","year":"2019","unstructured":"AJMC. How Advances in Precision Oncology Are Shaping a New Diagnostic and Treatment Frontier. Perspectives in Precision Oncology 2019 [cited 2021 September 16]; Available from: https:\/\/www.ajmc.com\/view\/how-advances-in-precision-oncology-new-diagnostic-and-treatment-frontier."},{"issue":"6","key":"4113_CR35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1503\/jpn.130221","volume":"38","author":"M Alda","year":"2013","unstructured":"Alda M. Personalized psychiatry: many questions, fewer answers. J Psychiatry Neurosci. 2013;38(6):363\u20135.","journal-title":"J Psychiatry Neurosci"},{"issue":"1","key":"4113_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.biopsych.2012.12.007","volume":"74","author":"RH Perlis","year":"2013","unstructured":"Perlis RH. A clinical risk stratification tool for predicting treatment resistance in major depressive disorder. Biol Psychiatry. 2013;74(1):7\u201314.","journal-title":"Biol Psychiatry"},{"issue":"7","key":"4113_CR37","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","volume":"167","author":"T Insel","year":"2010","unstructured":"Insel T, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167(7):748\u201351.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"4113_CR38","first-page":"223","volume":"3","author":"D Bzdok","year":"2018","unstructured":"Bzdok D, Meyer-Lindenberg A. Machine learning for precision psychiatry: opportunities and challenges. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3(3):223\u201330.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"6","key":"4113_CR39","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/fampra\/cmaa077","volume":"37","author":"M Balestrieri","year":"2020","unstructured":"Balestrieri M, et al. Effectiveness of clinical decision support systems and telemedicine on outcomes of depression: a cluster randomized trial in general practice. Fam Pract. 2020;37(6):731\u20137.","journal-title":"Fam Pract"},{"issue":"4","key":"4113_CR40","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4088\/PCC.08m00687","volume":"11","author":"BT Kurian","year":"2009","unstructured":"Kurian BT, et al. A computerized decision support system for depression in primary care. Prim Care Companion J Clin Psychiatry. 2009;11(4):140\u20136.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"7","key":"4113_CR41","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/archpsyc.61.7.669","volume":"61","author":"MH Trivedi","year":"2004","unstructured":"Trivedi MH, et al. Clinical results for patients with major depressive disorder in the Texas medication algorithm project. Arch Gen Psychiatry. 2004;61(7):669\u201380.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"4113_CR42","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4088\/JCP.v60n0302","volume":"60","author":"ML Crismon","year":"1999","unstructured":"Crismon ML, et al. The Texas medication algorithm project: report of the Texas consensus conference panel on medication treatment of major depressive disorder. J Clin Psychiatry. 1999;60(3):142\u201356.","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"4113_CR43","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"4113_CR44","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1176\/appi.psy.47.1.62","volume":"47","author":"B Lowe","year":"2006","unstructured":"Lowe B, et al. Responsiveness of the PHQ-9 to psychopharmacological depression treatment. Psychosomatics. 2006;47(1):62\u20137.","journal-title":"Psychosomatics"},{"key":"4113_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.genhosppsych.2015.11.005","volume":"39","author":"F Plummer","year":"2016","unstructured":"Plummer F, et al. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24\u201331.","journal-title":"Gen Hosp Psychiatry"},{"issue":"10","key":"4113_CR46","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"issue":"12","key":"4113_CR47","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/00005650-200412000-00006","volume":"42","author":"B Lowe","year":"2004","unstructured":"Lowe B, et al. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004;42(12):1194\u2013201.","journal-title":"Med Care"},{"key":"4113_CR48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jad.2020.01.032","volume":"265","author":"A Toussaint","year":"2020","unstructured":"Toussaint A, et al. Sensitivity to change and minimal clinically important difference of the 7-item generalized anxiety disorder questionnaire (GAD-7). J Affect Disord. 2020;265:395\u2013401.","journal-title":"J Affect Disord"},{"key":"4113_CR49","volume-title":"Designing and conducting survey research","author":"LM Rea","year":"1992","unstructured":"Rea LM, Parker RA. Designing and conducting survey research. San Francisco: Jossey-Boss; 1992."},{"key":"4113_CR50","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New Jersey: Lawrence Erlbaum; 1988.","edition":"2"},{"issue":"1","key":"4113_CR51","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1176\/appi.ps.201400051","volume":"66","author":"M Malowney","year":"2015","unstructured":"Malowney M, et al. Availability of outpatient care from psychiatrists: a simulated-patient study in three U.S. cities. Psychiatr Serv. 2015;66(1):94\u20136.","journal-title":"Psychiatr Serv"},{"issue":"8","key":"4113_CR52","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1176\/appi.ajp.161.8.1471","volume":"161","author":"PE Ruskin","year":"2004","unstructured":"Ruskin PE, et al. Treatment outcomes in depression: comparison of remote treatment through telepsychiatry to in-person treatment. Am J Psychiatry. 2004;161(8):1471\u20136.","journal-title":"Am J Psychiatry"},{"key":"4113_CR53","volume-title":"How Much Does a Psychiatrist Cost?","author":"Electronic Health Reporter","year":"2021","unstructured":"Electronic Health Reporter. How Much Does a Psychiatrist Cost? 2021 [cited 2022 February 20]; Available from: https:\/\/electronichealthreporter.com\/how-much-does-a-psychiatrist-cost\/#:~:text=While%20practices%20differ%2C%20patients%20canat%20least%2024100%20per%20hour ."},{"key":"4113_CR54","unstructured":"Naslund JA, et al. Economic evaluation and costs of telepsychiatry programmes: a systematic review. J Telemed Telecare. 2020:1357633X20938919."},{"issue":"10","key":"4113_CR55","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/jama.2016.12195","volume":"316","author":"GD Sanders","year":"2016","unstructured":"Sanders GD, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and Medicine. JAMA. 2016;316(10):1093\u2013103.","journal-title":"JAMA"},{"issue":"3","key":"4113_CR56","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/070674371005500303","volume":"55","author":"M Sinyor","year":"2010","unstructured":"Sinyor M, Schaffer A, Levitt A. The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review. Can J Psychiatr. 2010;55(3):126\u201335.","journal-title":"Can J Psychiatr"},{"issue":"4","key":"4113_CR57","doi-asserted-by":"publisher","first-page":"371","DOI":"10.31887\/DCNS.2008.10.4\/jmendlewicz","volume":"10","author":"J Mendlewicz","year":"2008","unstructured":"Mendlewicz J. Towards achieving remission in the treatment of depression. Dialogues Clin Neurosci. 2008;10(4):371\u20135.","journal-title":"Dialogues Clin Neurosci"},{"issue":"2","key":"4113_CR58","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0006-3223(01)01291-4","volume":"51","author":"RM Hirschfeld","year":"2002","unstructured":"Hirschfeld RM, et al. Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry. 2002;51(2):123\u201333.","journal-title":"Biol Psychiatry"},{"issue":"9","key":"4113_CR59","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1038\/sj.npp.1301131","volume":"31","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, et al. Report by the ACNP task force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006;31(9):1841\u201353.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"4113_CR60","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5498\/wjp.v6.i2.269","volume":"6","author":"S Hubley","year":"2016","unstructured":"Hubley S, et al. Review of key telepsychiatry outcomes. World J Psychiatry. 2016;6(2):269\u201382.","journal-title":"World J Psychiatry"},{"issue":"4","key":"4113_CR61","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/tmj.2020.0256","volume":"27","author":"K Haxhihamza","year":"2021","unstructured":"Haxhihamza K, et al. Patient satisfaction with use of telemedicine in University Clinic of Psychiatry: Skopje, North Macedonia during COVID-19 pandemic. Telemed J E Health. 2021;27(4):464\u20137.","journal-title":"Telemed J E Health"},{"issue":"1","key":"4113_CR62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10597-020-00724-2","volume":"57","author":"G Guaiana","year":"2021","unstructured":"Guaiana G, et al. A systematic review of the use of Telepsychiatry in depression. Community Ment Health J. 2021;57(1):93\u2013100.","journal-title":"Community Ment Health J"},{"issue":"1","key":"4113_CR63","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28\u201340.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"4113_CR64","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.psychres.2005.10.009","volume":"145","author":"RW Iannuzzo","year":"2006","unstructured":"Iannuzzo RW, et al. Development and reliability of the HAM-D\/MADRS interview: an integrated depression symptom rating scale. Psychiatry Res. 2006;145(1):21\u201337.","journal-title":"Psychiatry Res"},{"issue":"5","key":"4113_CR65","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00737-020-01042-y","volume":"23","author":"ME Gerbasi","year":"2020","unstructured":"Gerbasi ME, et al. Associations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton rating scale for depression. Arch Womens Ment Health. 2020;23(5):727\u201335.","journal-title":"Arch Womens Ment Health"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-022-04113-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T13:05:17Z","timestamp":1658235917000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-022-04113-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4113"],"URL":"https:\/\/doi.org\/10.1186\/s12888-022-04113-9","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"assertion":[{"value":"15 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The WCG IRB (), Ethics Committee Panel 1, approved the retrospective research analysis of clinical data obtained by Brightside as part of routine clinical care. All participants completed written consent documentation to participate in research. WCG IRB is registered with OHRP\/FDA; the IRB registration number is IRB00000533, parent organization number is IORG0000432.r WCG IRB\u2019s OHRP\/FDA IRB registration number (IRB00000533).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. O\u2019Callaghan, Dr. Belanger, Mr. Sullivan and Dr. Winsberg all hold stock in Brightside Health Inc. Dr. O\u2019Callaghan, Mr. Sullivan, Ms. Gupta, Dr. Belanger, and Dr. Winsberg are all employees of Brightside Health, Inc. As such, the funding body took part in the design of the study and collection, analysis, and interpretation of data, and the writing of the manuscript. All participants in this study received psychiatric healthcare at Brightside Health Inc., a mental healthcare company. All authors of the submitted manuscript are employees of Brightside Health.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"483"}}